NOC•October 20, 2026 at 10:06 AM UTCCapital Goods

Northrop Grumman Releases Q3 2026 Results; Focus Shifts to B-21 EAC and Cash Flow Details

Read source article

What happened

Northrop Grumman issued its third-quarter 2026 earnings release on October 20, 2026, but the press notice contains no financial details. The latest DeepValue master report, based on Q1 2026 data, rates NOC a WAIT with a base scenario of $575 and highlights a $1.0B B-21 loss accrual and a $157M net unfavorable EAC adjustment on the first four LRIP lots. The thesis hinges on whether subsequent quarterly filings show B-21 learning-curve progress, a declining loss accrual, and Sentinel baseline establishment. Q3 results are the first major checkpoint within the report's 3-6 month reassessment window, and investors will scrutinize whether the loss accrual declined and whether operating cash flow improved from Q1's negative $1.656B. Because the release contains no numbers, its market impact depends entirely on the yet-to-be-reviewed details in the 10-Q.

Implication

If Q3 shows a material reduction in the B-21 loss accrual (below $0.8B) and favorable EAC adjustments, the base case strengthens, supporting entry near current levels. Conversely, if the loss accrual remains at $1.0B or higher and EAC adjustments stay unfavorable, the bear case gains credibility, and the stock could slide toward the $450 scenario. Cash flow performance is critical: repeated negative operating cash flow would signal structural issues beyond timing, contradicting the normalization assumption. Sentinel disclosures in Q3 should be checked for progress on the new baseline or Milestone B, as lack of progress keeps that overhang alive. Until the actual 10-Q is filed, the WAIT rating remains appropriate, and no thesis change is warranted purely from the release announcement.

Thesis delta

The thesis remains unchanged pending review of Q3 details; the master report's WAIT rating is predicated on observable de-risking within 3-6 months. Q3 is within that window, so the results are pivotal but not yet known. If the filing shows B-21 loss accrual reduction and favorable EAC movement, the thesis would shift toward the base case; otherwise, the bear case probability rises.

Confidence

Medium